Continuing Education for Nurses and Social Workers

GOAL
To educate oncology nurses and social workers about myeloma treatment and side effect management

OBJECTIVES
At the conclusion of this program, participants should be able to:

• Explain current and emerging treatment options for myeloma
• Describe the role of clinical trials and potential benefits of participation
• Identify possible myeloma symptoms and treatment for side effect management
• Identify quality of life issues for people living with myeloma

TARGET AUDIENCE
Oncology nurses and social workers involved in the treatment of myeloma

CERTIFICATION
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: 12/2008-12/2011. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.5 CE clinical clock hours.

Upon completion of this program and submission of the activity evaluation, a certificate of completion will be issued to you via
e-mail or US mail within 30 days.

SUPPORT STATEMENT
This program is supported by grants from Celgene Corporation and Millennium Pharmaceuticals, Inc.

Print This Page